Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Glossary toggle added and capitalization fixes for labels, such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' plus the site revision banner updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T01:39:46.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3 in the page footer, indicating a minor version update that does not alter trial content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:57:15.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Minor formatting changes were made to the study's location section: the header changed from 'Pennsylvania Locations' to 'Locations' with a subheading 'Pennsylvania', and the page revision tag was updated; the 'HHS Vulnerability Disclosure' footer link was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T17:21:37.000Z thumbnail image
  5. Check
    70 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:00:13.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Removed the government funding and operating status notice from the page; core study details such as inclusion criteria, endpoints, and treatment information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:16:28.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The study status is updated to Terminated due to slow patient accrual. Results have been added with Results First Posted on 2020-09-16.
    Difference
    0.4%
    Check dated 2025-11-03T12:53:07.000Z thumbnail image

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.